Adagio Medical Receives IDE Approval from the FDA to Investigate Next-Generation vCLAS® Ventricular Ablation System

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that the U.S.
Neurology Advisor

AI Model Predicts Mortality in Patients With Gunshot Wounds to the Head

AI model using head CT imaging predicts in-hospital mortality for patients with gunshot wounds to the head with high discriminative performance.
MassDevice

Adagio Medical wins FDA IDE to expand ventricular ablation study to use next-gen catheter

Adagio Medical (Nasdaq:ADGM) announced today that it received FDA investigational device exemption (IDE) to expand its ...
MassDevice

KingstronBio reports first implant of mitral valve replacment system

KingstronBio announced today that it completed the first implant of its ProStyle M transcatheter mitral valve replacement ...
InvestorsHub on MSN

Adagio Medical secures FDA clearance to broaden ventricular ablation study

Adagio Medical Holdings Inc. (NASDAQ:ADGM) said it has received Investigational Device Exemption (IDE) authorization from the ...
The Manila Times

First Implant of KingstronBio's ProStyle M® Transcatheter Mitral Valve System Successfully Completed in National Multicenter Confirmatory Study

On March 12, 2026, the first implant of the ProStyle M® Transcatheter Mitral Valve System (ProStyle M®) was successfully ...

To fix a patient’s irregular heartbeat, doctors first tested its digital ‘twin’

Scientists at Johns Hopkins University are creating virtual replicas of patients’ hearts so they can test how to fix a ...
The Cardiology Advisor

Managing Pediatric Left-to-Right Shunt Lesions: New ACC Clinical Guidance

The ACC issued new guidance for managing common pediatric left-to-right shunts, including ASD, VSD, and PDA, in the ...

Catheter Precision to Attend the Annual European Heart Rhythm Association Conference

FORT MILL, S.C., April 08, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK” or the “Company”) today announced that it will be attending the annual European Heart Rhythm ...
TMCnet

SoloPace Announces US Commercial Release of the SOLO PACE FUSION Temporary Pacing System Following FDA 510(k) Clearance

SoloPace FUSION is a single use, sterile kit designed to streamline temporary intracardiac pacing for transcatheter aortic ...
Yahoo Finance

Adagio Medical Highlights Recent Successful Expanded Access Cases with vCLAS™ System, Including Patients with Premature Ventricular Contractions (PVC)

LAGUNA HILLS, Calif., March 19, 2026--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment ...